small molecule

ALLEGRA

FEXOFENADINE HYDROCHLORIDE

Loss of exclusivityloss of exclusivity
CompanyCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Drug detail

Brand nameALLEGRA
Active ingredientFEXOFENADINE HYDROCHLORIDE
Strength60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 1996
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ALLEGRA patent cliff — loss of exclusivity — | CliffBio